ATC code L03
| ATC codes |
|---|
| L Antineoplastic and immunomodulating agents |
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
ATC code L03 Immunostimulants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup L03 is part of the anatomical group L Antineoplastic and immunomodulating agents.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L03A Immunostimulants
L03AA Colony stimulating factors
- L03AA02 Filgrastim
- L03AA03 Molgramostim
- L03AA09 Sargramostim
- L03AA10 Lenograstim
- L03AA12 Ancestim
- L03AA13 Pegfilgrastim
- L03AA14 Lipegfilgrastim
- L03AA15 Balugrastim
- L03AA16 Empegfilgrastim
- L03AA17 Pegteograstim
- QL03AA90 Pegbovigrastim
L03AB Interferons
- L03AB01 Interferon alfa natural
- L03AB02 Interferon beta natural
- L03AB03 Interferon gamma
- L03AB04 Interferon alfa-2a
- L03AB05 Interferon alfa-2b
- L03AB06 Interferon alfa-n1
- L03AB07 Interferon beta-1a
- L03AB08 Interferon beta-1b
- L03AB09 Interferon alfacon-1
- L03AB10 Peginterferon alfa-2b
- L03AB11 Peginterferon alfa-2a
- L03AB12 Albinterferon alfa-2b
- L03AB13 Peginterferon beta-1a
- L03AB14 Cepeginterferon alfa-2b
- L03AB15 Ropeginterferon alfa-2b
- L03AB16 Peginterferon alfacon-2
- L03AB60 Peginterferon alfa-2b, combinations
- L03AB61 Peginterferon alfa-2a, combinations
- QL03AB90 Interferom omega, feline origin
L03AC Interleukins
- L03AC01 Aldesleukin
- L03AC02 Oprelvekin
L03AX Other immunostimulants
- L03AX01 Lentinan
- L03AX02 Roquinimex
- L03AX03 BCG vaccine
- L03AX04 Pegademase
- L03AX05 Pidotimod
- L03AX07 Poly I:C
- L03AX08 Poly ICLC
- L03AX09 Thymopentin
- L03AX10 Immunocyanin
- L03AX11 Tasonermin
- L03AX12 Melanoma vaccine
- L03AX13 Glatiramer acetate
- L03AX14 Histamine dihydrochloride
- L03AX15 Mifamurtide
- L03AX16 Plerixafor
- L03AX17 Sipuleucel-T
- L03AX18 Cridanimod
- L03AX19 Dasiprotimut-T
- L03AX21 Elapegademase
- QL03AX90 Feline interleukin-2 recombinant canarypox virus (viral vector)
References
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ↑ "ATC/DDD Index 2022: code L03". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2022: code QL03". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.